Sold Out
Book Categories |
Series Introduction | ||
Foreword | ||
Preface | ||
Contributors | ||
Acknowledgements | ||
Tumor-Associated Antigens and the Role of Antibodies and Cellular Immunity in Cancer | 1 | |
The Immunogenicity of Foreign Monoclonal Antibodies in Human Disease Applications: Problems and Current Approaches | 3 | |
Additive and Synergistic Interactions of Monoclonal Antibodies and Immunotoxins Reactive with Breast and Ovarian Cancer | 23 | |
Tumor Rejection Antigens of the Chemically Induced BALB/C Meth A Sarcoma | 31 | |
Antitumor Effector Cells: Characteristics and Basic Mechanisms | 37 | |
Phenotypic and Functional Characteristics of Human A-NK Cells | 41 | |
Regulation and Function of Fibronectin Receptors Expressed by Natural Killer Cells | 55 | |
Growth Requirements, Binding and Migration of Human Natural Killer Cells | 63 | |
Regulation of Monocytes by IL-2-Activated Killer Cells | 75 | |
Identification and Enrichment of Proteolytic Enzymes of IL-2 Activated Rat Natural Killer (A-NK) Cells: Potential Physiological Roles in NK Cell Function | 83 | |
Animal Models in Tumor Biology | 93 | |
Effects of rhIL-7 on Leukocyte Subsets in Mice: Implications for Antitumor Activity | 95 | |
Up-Regulation of Tumor Cell Sensitivity to Natural Cell-Mediated Cytotoxicity by UV Light Irradiation | 105 | |
Studies on NK Cell Precursors in Mice | 125 | |
Tumor Microenvironment and Immune Effector Cells | 133 | |
Tumor-Infiltrating Lymphocytes in Human Solid Tumors | 137 | |
Localization of Immune Effector Cells to Tumor Metastases | 149 | |
Antitumor Effector Cells: Extravasation and Control of Metastasis | 159 | |
Tumor Microenvironment and Immune Effector Cells: Isolation, Large Scale Propagation and Characterization of CD8[superscript +] Tumor Infiltrating Lymphocytes From Renal Cell Carcinomas | 175 | |
Immunomodulation and Antitumor Mechanisms | 179 | |
Interleukin-Induced Tumor Immunogenicity | 183 | |
Biological Significance of Autologous Tumor Killing | 195 | |
Biological Response Modifiers and Chemotherapeutic Agents that Alter Interleukin 2 Activities | 207 | |
Immunotherapy of Tumors | 227 | |
New Perspectives in Immunotherapy of Leukemia | 231 | |
The Role of Interferons in the Therapy of Melanoma | 239 | |
Therapy with Interleukin-2 and Tumor-Derived Activated Lymphocytes | 251 | |
Combination Cytokine Therapy in Cancer | 273 | |
Anti-Idiotype Antibodies: Novel Therapeutic Approach to Cancer Therapy | 281 | |
Immunity and Cancer Therapy: Present Status and Future Projections | 293 | |
Index | 311 |
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish ListX
This item is in your CollectionTumor Immunology and Cancer Therapy, Vol. 61
X
This Item is in Your InventoryTumor Immunology and Cancer Therapy, Vol. 61
X
You must be logged in to review the productsX
X
X
Add Tumor Immunology and Cancer Therapy, Vol. 61, , Tumor Immunology and Cancer Therapy, Vol. 61 to the inventory that you are selling on WonderClubX
X
Add Tumor Immunology and Cancer Therapy, Vol. 61, , Tumor Immunology and Cancer Therapy, Vol. 61 to your collection on WonderClub |